Literature DB >> 19201118

Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitisC.

N Kabbaj1, S Sentissi, M Mohammadi, A Benaïssa, N Amrani.   

Abstract

Ophthalmological complications with interferon therapy are rare, usually mild and reversible, and do not require the withdrawal of antiviral treatment. Anterior ischemic optic neuropathy is an uncommon complication of interferon treatment. From January 1998 to December 2007, three patients developed anterior ischemic optic neuropathy during antiviral treatment, with a favourable course after interferon was discontinued. Periodic Ophthalmological examinations, including visual acuity and fundus examinations should be performed before starting and during treatment, particularly in patients with vascular risk factors. Antiviral therapy should be stopped immediately if severe ophthalmologic complications occur.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201118     DOI: 10.1016/j.gcb.2008.12.004

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

1.  Pegylated interferon alpha-associated optic neuropathy.

Authors:  Kathleen T Berg; Bruce Nelson; Andrew R Harrison; Linda K McLoon; Michael S Lee
Journal:  J Neuroophthalmol       Date:  2010-06       Impact factor: 3.042

2.  Irreversible anterior ischemic optic neuropathy complicating interferon alpha and ribaverin therapy.

Authors:  Hassan Seddik; Mouna Tamzaourte; Fadoua Rouibaa; Maha Fadlouallah; Ahmed Benkirane
Journal:  Int J Hepatol       Date:  2010-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.